GPhA VP Simmon departs
Generic Pharmaceutical Association VP-Public Affairs & Development Christine Simmon is leaving "to pursue other opportunities in pharmaceutical and healthcare policy," the association says. Simmon, who will depart in March, joined GPhA as vice president of policy and public affairs in 2002 from the BlueCross BlueShield Association (1"The Pink Sheet" Dec. 16, 2002, p. 21)...
You may also be interested in...
The Generic Pharmaceutical Association is adding a legislative staffer to concentrate on Republican lobbying
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.